Paolo Ghia Selected Research

Peptides (Polypeptides)

1/2021	Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.
11/2005	Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Ghia Research Topics

Disease

135	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 03/2003
37	Neoplasms (Cancer) 02/2024 - 03/2003
15	Disease Progression 01/2023 - 07/2006
12	Infections 07/2023 - 01/2017
9	Hemorrhage 07/2023 - 12/2015
8	Diarrhea 09/2023 - 12/2015
8	Neutropenia 07/2023 - 12/2015
8	Leukemia 02/2022 - 08/2004
7	Atrial Fibrillation 07/2023 - 10/2017
7	COVID-19 01/2023 - 01/2020
7	Residual Neoplasm 01/2023 - 01/2012
7	Lymphoma (Lymphomas) 01/2022 - 09/2002
6	B-Cell Lymphoma (Lymphoma, B Cell) 07/2023 - 05/2013
6	Lymphocytosis 07/2023 - 07/2009
4	Fatigue 09/2023 - 12/2015
4	Hypertension (High Blood Pressure) 07/2023 - 01/2019
4	Tumor Lysis Syndrome 10/2022 - 01/2019
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 09/2011
3	Nausea 09/2023 - 12/2015
3	Cough 01/2023 - 12/2015
3	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 09/2013
2	Inflammation (Inflammations) 03/2024 - 10/2017
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 12/2020
2	Vomiting 09/2023 - 12/2015
2	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023 - 07/2021
2	Headache (Headaches) 01/2023 - 01/2021
2	Arthralgia (Joint Pain) 01/2023 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2019
2	Multiple Myeloma 04/2020 - 05/2003
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2019
2	Pneumonia (Pneumonitis) 01/2019 - 01/2017
2	Anemia 12/2018 - 12/2015
2	Fever (Fevers) 12/2018 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2004 - 06/2003
1	Sudden Death 04/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024
1	Multiple Sclerosis 03/2024
1	Melanoma (Melanoma, Malignant) 11/2023
1	Pain (Aches) 09/2023
1	Spasm (Spasms) 01/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023

Drug/Important Bio-Agent (IBA)

40	ibrutinibIBA 05/2024 - 12/2015
28	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 03/2004
20	Agammaglobulinaemia Tyrosine KinaseIBA 05/2024 - 01/2016
19	AntigensIBA 01/2023 - 08/2004
17	acalabrutinibIBA 05/2024 - 01/2016
15	Rituximab (Mabthera)FDA Link 11/2023 - 09/2012
10	Chlorambucil (Leukeran)FDA Link 01/2023 - 12/2015
9	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2024 - 11/2011
9	idelalisibIBA 01/2021 - 03/2014
8	Bendamustine Hydrochloride FDA Link 09/2023 - 09/2014
7	venetoclaxIBA 07/2023 - 01/2021
7	Proteins (Proteins, Gene)FDA Link 12/2020 - 06/2005
6	fludarabineIBA 11/2023 - 05/2015
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 09/2012
6	ofatumumab FDA Link 01/2022 - 04/2015
5	zanubrutinibIBA 02/2024 - 10/2020
5	Immunoglobulin M (IgM)IBA 01/2022 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 04/2022 - 05/2015
4	obinutuzumabIBA 01/2022 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 10/2023 - 04/2016
3	Messenger RNA (mRNA)IBA 11/2022 - 06/2015
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2020
3	EpitopesIBA 01/2021 - 11/2005
3	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2021 - 01/2007
3	CytokinesIBA 01/2020 - 10/2003
3	ChemokinesIBA 10/2019 - 06/2003
3	Immunoglobulin D (IgD)IBA 01/2019 - 01/2014
3	Ribonucleases (Ribonuclease)IBA 04/2015 - 01/2011
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 04/2024 - 02/2008
2	pirtobrutinibIBA 07/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2023 - 02/2019
2	Monoclonal AntibodiesIBA 01/2023 - 01/2021
2	VaccinesIBA 01/2023 - 07/2021
2	Complement System Proteins (Complement)IBA 11/2022 - 08/2018
2	BNT162 VaccineIBA 11/2022 - 10/2021
2	Bortezomib (Velcade)FDA Link 01/2022 - 04/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2016
2	Lenalidomide (CC 5013)FDA Link 01/2022 - 10/2017
2	Chimeric Antigen ReceptorsIBA 01/2022 - 05/2011
2	Peptides (Polypeptides)IBA 01/2021 - 11/2005
2	IronIBA 12/2020 - 04/2020
2	duvelisibIBA 01/2020 - 12/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 12/2018
2	serum P-component (CIt)IBA 11/2018 - 01/2018
2	AutoantigensIBA 11/2017 - 12/2007
2	Antigen Receptors (Antigen Receptor)IBA 10/2017 - 08/2014
2	MicroRNAs (MicroRNA)IBA 05/2013 - 05/2010
1	AntioxidantsIBA 03/2024
1	Dimethyl FumarateIBA 03/2024
1	Glutathione (Reduced Glutathione)IBA 03/2024
1	dimethyl itaconateIBA 10/2023
1	Phospholipases (Phospholipase)IBA 01/2023

Therapy/Procedure

41	Therapeutics 04/2024 - 09/2002
3	Immunotherapy 01/2021 - 11/2005
2	Duration of Therapy 07/2023 - 09/2022
2	Salvage Therapy 01/2019 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2018 - 03/2014